ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1440

Lupus-Prone Mice Demonstrate Enhanced Neutrophil Extracellular Trap Formation: Implications for Autoantibody Formation and Organ Damage

Jason S. Knight1, Alexander A. O'Dell1, Wenpu Zhao2, Ritika Khandpur2, Srilakshmi Yalavarthi2 and Mariana J. Kaplan3, 1Department of Internal Medicine, Division of Rheumatology, University of Michigan, Ann Arbor, MI, 2University of Michigan Rheumatology, Ann Arbor, MI, 3Systemic Autoimmunity Branch, National Institutes of Health/NIAMS, Bethesda, MD

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Animal models, autoantibodies, interferons, neutrophils and systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Systemic Lupus Erythematosus - Animal Models

Session Type: Abstract Submissions (ACR)

Background/Purpose: Recent evidence suggests that enhanced neutrophil extracellular trap (NET) formation—the programmed release of chromatin fibers decorated with granular antimicrobial peptides—is as an important activator of plasmacytoid dendritic cells in systemic lupus erythematosus (SLE).  We have proposed that NETosis is also linked to skin, kidney, and premature vascular damage in human SLE. Understanding the role of NETosis in murine models of lupus will be crucial to further investigations of the pathogenic role of this process in autoimmune diseases.

Methods: The New Zealand Mixed (NZM) 2328 model of murine lupus was utilized, with BALB/c and C57BL/6 mice as non-autoimmune controls. Percentage of neutrophils undergoing NETosis was assayed both at baseline and upon exposure to NZM or control serum.  Autoantibodies (autoAbs) to NET proteins were characterized by immunofluorescence, western blotting, and in-house ELISAs for Abs to the LL-37 mouse orthologue CRAMP and to NET proteins in general. Glomerular and skin NET-like material were detected by immunofluorescence analysis.

Results: NZM neutrophils demonstrated enhanced spontaneous NETosis (7.13% ± 1.16 vs. 1.83% ± 0.25; p=0.0008) as compared to control BALB/c neutrophils; further, incubation of control neutrophils with NZM serum increased NETosis percentage to levels observed in NZM neutrophils. The NET-stimulating effect of NZM serum was also robust in type I interferon receptor-knockout neutrophils, suggesting that serum factors other than these cytokines contribute to the phenotype. NZM mice develop anti-NET autoAbs. Immunofluorescence analysis using NZM serum as primary Ab demonstrated a granular pattern of reactivity with NETs, which in many places co-localized with anti-myeloperoxidase (MPO) and anti-neutrophil elastase (NE) staining. Using similar methodology, western blotting revealed NZM serum reactivity with specific proteins derived from NETs. By ELISA, NZM serum reacted more strongly with CRAMP (1.98 ± 0.19 vs. 1.00 ± 0.14; p=0.017) and NET proteins (1.85 ± 0.16 vs. 1.00 ± 0.090; p=0.014) than age-matched control serum.  NET-like material—consisting of DNA, MPO, and NE—was detected in nephritic NZM kidneys and in non-affected NZM skin, but not in control mice.

Conclusion: The NZM2328 murine model of lupus replicates a number of the features of human SLE with regards to aberrant neutrophil function. These include enhanced NETosis, anti-NET autoAb formation, and the potential for organ damage attributable to NETs. Future studies should better dissect the role of NETosis both in driving lupus pathogenesis and in contributing to organ damage such as skin disease, nephritis, and accelerated atherosclerosis.


Disclosure:

J. S. Knight,
None;

A. A. O’Dell,
None;

W. Zhao,
None;

R. Khandpur,
None;

S. Yalavarthi,
None;

M. J. Kaplan,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/lupus-prone-mice-demonstrate-enhanced-neutrophil-extracellular-trap-formation-implications-for-autoantibody-formation-and-organ-damage/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology